$216 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 58 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 15.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences Inc | $20,046,000 | -6.2% | 316,284 | 0.0% | 9.26% | +16.9% | |
| CELG | Buy | Celgene Corp | $16,981,000 | +28.9% | 171,022 | +20.0% | 7.85% | +60.7% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $14,232,000 | -8.7% | 84,022 | -1.2% | 6.58% | +13.8% |
| NBIX | Sell | Neurocrine Biosciences Inc | $13,266,000 | +0.2% | 147,300 | -6.1% | 6.13% | +24.9% |
| AMGN | Amgen Inc | $12,772,000 | +5.0% | 66,000 | 0.0% | 5.90% | +30.9% | |
| REGN | Buy | Regeneron Pharmaceuticals | $11,050,000 | +51.4% | 39,830 | +70.7% | 5.11% | +88.7% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $10,002,000 | -22.6% | 102,141 | +3.5% | 4.62% | -3.5% |
| STML | Buy | Stemline Therapeutics Inc | $8,695,000 | -23.7% | 835,245 | +12.2% | 4.02% | -5.0% |
| PTCT | Sell | PTC Therapuetics COM | $7,982,000 | -31.4% | 236,000 | -8.9% | 3.69% | -14.5% |
| ILMN | ILLUMINA INC | $7,636,000 | -17.4% | 25,100 | 0.0% | 3.53% | +3.0% | |
| BIIB | Sell | Biogen Inc | $7,381,000 | -26.1% | 31,700 | -25.8% | 3.41% | -7.9% |
| INCY | Buy | Incyte Corp | $7,161,000 | +6.7% | 96,500 | +22.2% | 3.31% | +33.0% |
| INSM | INSMED INC | $6,287,000 | -31.0% | 356,600 | 0.0% | 2.90% | -14.0% | |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $5,938,000 | +92.9% | 218,000 | +70.3% | 2.74% | +140.5% |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $5,883,000 | +6.8% | 87,284 | +35.8% | 2.72% | +33.2% |
| SGEN | Buy | Seattle Genetics Inc | $5,667,000 | +34.4% | 66,400 | +9.0% | 2.62% | +67.6% |
| AMRN | Buy | Amarin Corp Plcspons adr new | $3,926,000 | +47.9% | 259,000 | +89.1% | 1.81% | +84.3% |
| SGMO | Buy | Sangamo Therapeutics Inc | $3,168,000 | +96.0% | 350,000 | +133.3% | 1.46% | +144.4% |
| IONS | Sell | Ionis Pharmaceuticals Inc | $2,767,000 | -48.0% | 46,181 | -44.2% | 1.28% | -35.2% |
| ALNY | Alnylam Pharmaceuticals Inc | $2,715,000 | +10.7% | 33,800 | 0.0% | 1.26% | +37.9% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,446,000 | +72.9% | 68,000 | +28.3% | 1.13% | +115.2% |
| GWPH | Buy | GW Pharmaceuticals Plcads | $2,276,000 | +20.0% | 19,800 | +80.0% | 1.05% | +49.6% |
| SAGE | Sell | Sage Therapeutics Inc | $2,245,000 | -63.9% | 16,000 | -52.9% | 1.04% | -55.1% |
| ABMD | Abiomed Inc | $2,081,000 | -31.7% | 11,700 | 0.0% | 0.96% | -14.9% | |
| KALV | Sell | Kalvista Pharmaceuticals Inc | $2,058,000 | -50.6% | 177,433 | -5.4% | 0.95% | -38.4% |
| SRPT | Sarepta Therapeutics Inc | $1,966,000 | -50.4% | 26,100 | 0.0% | 0.91% | -38.2% | |
| RGEN | REPLIGEN CORP | $1,841,000 | -10.7% | 24,000 | 0.0% | 0.85% | +11.4% | |
| EXEL | Sell | Exelixis Inc | $1,830,000 | -80.7% | 103,534 | -76.7% | 0.85% | -75.9% |
| MYOK | Myokardia INC | $1,564,000 | +3.9% | 30,000 | 0.0% | 0.72% | +29.6% | |
| BLUE | Bluebird Bio Inc | $1,561,000 | -27.8% | 17,000 | 0.0% | 0.72% | -10.1% | |
| ASND | Sell | Ascendis Pharma ASsponsored adr | $1,329,000 | -55.2% | 13,800 | -46.5% | 0.61% | -44.2% |
| MLND | Millendo Therapeutics Inc | $1,264,000 | -38.5% | 177,825 | 0.0% | 0.58% | -23.4% | |
| STRO | Sell | SUTRO BIOPHARMA INC | $1,264,000 | -23.0% | 139,331 | -4.0% | 0.58% | -4.1% |
| BPMC | Blueprint Medicines Corp | $1,250,000 | -22.1% | 17,000 | 0.0% | 0.58% | -2.9% | |
| GMED | Globus Med Inc | $1,237,000 | +20.8% | 24,200 | 0.0% | 0.57% | +50.5% | |
| XLRN | ACCELERON PHARMA INC | $1,184,000 | -4.0% | 30,000 | 0.0% | 0.55% | +19.7% | |
| AGIO | Agios Pharmaceuticals Inc | $1,180,000 | -35.2% | 36,500 | 0.0% | 0.54% | -19.3% | |
| TCDA | Buy | Tricida Inc | $1,141,000 | +44.8% | 37,000 | +85.0% | 0.53% | +80.5% |
| NKTR | NEKTAR THERAPEUTICS | $1,093,000 | -48.8% | 60,000 | 0.0% | 0.50% | -36.2% | |
| QURE | UNIQURE NV | $1,082,000 | -49.6% | 27,500 | 0.0% | 0.50% | -37.2% | |
| MNTA | MOMENTA PHARMACEUTICALS INC | $1,036,000 | +3.9% | 80,000 | 0.0% | 0.48% | +29.5% | |
| EXAS | Exact Sciences Corp | $967,000 | -23.4% | 10,700 | 0.0% | 0.45% | -4.5% | |
| GBT | Sell | Global Blood Therapeutics | $897,000 | -39.1% | 18,500 | -33.9% | 0.42% | -24.0% |
| MRTX | MIRATI THERAPEUTICS INC | $849,000 | -24.4% | 10,900 | 0.0% | 0.39% | -5.8% | |
| HALO | Sell | Halozyme Therapeutics Inc | $816,000 | -90.0% | 52,633 | -88.9% | 0.38% | -87.5% |
| ARNA | Arena Pharmaceuticals Inc | $755,000 | -21.9% | 16,500 | 0.0% | 0.35% | -2.8% | |
| FGEN | FibroGen Inc | $728,000 | -18.1% | 19,700 | 0.0% | 0.34% | +1.8% | |
| MYGN | Sell | Myriad Genetics inc | $716,000 | -35.6% | 25,000 | -37.5% | 0.33% | -19.7% |
| ZGNX | Zogenix Inc | $577,000 | -16.0% | 14,400 | 0.0% | 0.27% | +4.7% | |
| DCPH | New | DECIPHERA PHARMACEUTICALS INC | $577,000 | – | 17,000 | +100.0% | 0.27% | – |
| SUPN | Supernus Pharmaceuticals Inc | $548,000 | -16.8% | 19,953 | 0.0% | 0.25% | +3.7% | |
| AKCA | AKCEA THERAPEUTICS INC | $488,000 | -34.3% | 31,723 | 0.0% | 0.23% | -17.8% | |
| FOLD | Amicus Therapeutics Inc | $470,000 | -35.6% | 58,600 | 0.0% | 0.22% | -19.9% | |
| RDUS | Radius Health Inc | $437,000 | +5.6% | 17,000 | 0.0% | 0.20% | +32.0% | |
| ANAB | New | ANAPTYSBIO INC | $350,000 | – | 10,000 | +100.0% | 0.16% | – |
| ARQL | Sell | Arqule INC | $294,000 | -88.8% | 41,000 | -82.9% | 0.14% | -86.1% |
| GTHX | Sell | G1 Therapeutics Inc | $255,000 | -94.3% | 11,200 | -92.3% | 0.12% | -92.9% |
| DERM | Dermira Inc | $191,000 | -33.4% | 30,000 | 0.0% | 0.09% | -17.0% | |
| RTRX | Exit | Retrophin Inc | $0 | – | -18,000 | -100.0% | -0.13% | – |
| PRQR | Exit | PROQR therapeutics N V | $0 | – | -56,000 | -100.0% | -0.19% | – |
| LGND | Exit | Ligand Pharmaceuticals Inc | $0 | – | -7,300 | -100.0% | -0.31% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -70,000 | -100.0% | -0.31% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -70,000 | -100.0% | -0.59% | – |
| XENT | Exit | Intersect Ent Inc | $0 | – | -96,000 | -100.0% | -0.81% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -50,949 | -100.0% | -0.83% | – |
| IOVA | Exit | Iovance Biotherapeutics INC | $0 | – | -104,000 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.